C oronary artery ectasia (CAE) is a vascular phenotype that is infrequently observed in patients who undergo coronary angiography. [1] [2] [3] [4] [5] [6] It is characterized by abnormal vessel dilatation associated with disturbed coronary flow. 7, 8 Although CAE has been shown to be associated with enhanced thrombogenicity and inflammatory reactions, such as activation of tumor necrosis factor-α and interleukin-1β, 8 the clinical significance of CAE has not been fully elucidated yet.
Although CAE is uncommonly seen on coronary angiography, several case reports showed acute occlusion at the ectatic coronary segment within infarct-related arteries in patients with acute myocardial infarction (AMI). 9, 10 In these cases, thrombectomy catheters retrieved substantial amounts of thrombus around ectatic lesions. 10 Postmortem pathological studies also demonstrated spontaneous occlusion of dilated coronary arteries because of the presence of massive thrombi.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Prevalence and Angiographic Characteristics of CAE
Patient disposition is shown in Figure 1 . In the current study, CAE was observed in 89 coronary arteries of 51 patients (3.0% of patients; 95% confidence interval [CI], 2.1-4.3).
Representative cases of classical and alternative definition of CAE is illustrated in Figure 2 . The conventional definition of CAE was applied in 67% (n=34) of CAE subjects, and the alternate definition was applied in the remaining cases (33%, n=17). Overall, the CAEs were located in 29 infarct-related arteries and 60 noninfarct related arteries, respectively. One patient each in CAE subjects had polycystic kidney disease and Ehlers-Danlos syndrome. None of patients with CAE had any angiographic coronary dissection and fibromuscular dysplasia. Table 1 summarizes the clinical characteristics of CAE. CAE was more frequently observed within the right coronary artery (39 of 51; 76%), followed by the left circumflex artery (28 of 51; 55%), left anterior descending artery (22 of 51; 43%), and left main trunk (10 of 51; 20%). Fifty-nine percent of CAE subjects showed multivessel CAE involvement. With regard to angiographic features of CAE, oscillatory and static flow were observed in 47% (24 of 51) and 27% (14 of 51) of patients with CAE, respectively. Of particular interest was that 37% (19 of 51) of patients with CAE exhibited concomitant dilatation of other vessels, including thoracic aorta (8%), abdominal aorta (8%), iliac artery (4%), and intracranial arteries (8%). One patient (2%) had both iliac and intracranial artery aneurysms. Dissecting aortic aneurysm was identified in 4 patients (8%).
Baseline Clinical Demographics in Patients With CAE
Baseline clinical demographics in patients with and without CAE are shown in Table 2 
Lesion Characteristics and Percutaneous Coronary Intervention Procedures
Lesion characteristics and details on percutaneous coronary intervention procedures are summarized in Table 2 and  Table II Figure 1 . Flowchart of the study subjects. AMI indicates acute myocardial infarction; and CAE, coronary artery ectasia.
Figure 2. Definition of coronary artery ectasia (CAE)
. CAE was defined as coronary artery dilatation of >1.5-fold the diameter of adjacent normal coronary segments (asterisk; A). In subjects who did not have adjacent normal segments (arrows; B), the mean diameter of each coronary segment in 51 age-and sexmatched patients without heart disease were assigned as a normal reference diameter, and a 1.5-fold difference in diameter between affected and normal reference diameter was used to define CAE.
As a consequence, the proportion of patients who achieved Thrombolysis in Acute Myocardial Infarction flow grade 3 was significantly lower in CAE subjects (45% versus 88%; P<0.001; Figure 1 ). Figure 3 , Tables 3 and 4, and Tables IV and V in Table 4 ; Tables IV and V in the online-only Data Supplement). These associations were further analyzed using propensity score-matching analysis, which selected 49 patients in each of the CAE and Categorical variables are expressed as n (%), and continuous variables as mean±SD or median (interquartile range). Major coronary risk factors include hypertension, diabetes mellitus, dyslipidemia, and smoking. ACE-I indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; CAE, coronary artery ectasia; CK, creatine kinase; CRP, C-reactive protein; DAPT, dual antiplatelet therapy; HDL cholesterol, high-density lipoprotein cholesterol; LDL cholesterol, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; and STEMI, ST-segment-elevation myocardial infarction.
Long-Term Outcomes in Patients With CAE
non-CAE groups. In this model, there were no significant differences in clinical characteristics between the 2 groups (Table VI in the online-only Data Supplement). Even in this propensity score-matched cohort, the frequency of MACE was still significantly higher in patients with CAE (HR, 8.98; 95% CI, 1.14-71.0; P=0.03).
Anticoagulation Therapy and MACE in Subjects With CAE
Of the 51 patients with CAE, 19 were treated with warfarin at the time of discharge. Of these, 8 achieved the percent time in the target therapeutic range (%TTR ≥60%). During the observation period, the occurrence of MACE was not observed in these patients. By contrast, the incidence of MACE was considerably higher in patients with %TTR <60% or in those who did not take warfarin (14 of 43; 33%; P=0.03; Figure 4 ).
Discussion
Although CAE is associated with abnormal vessel dilatation, disturbed coronary flow, and enhanced thrombogenicity, its association with cardiac events has not been fully characterized. Our study demonstrated that (1) 3% of patients with AMI harbored CAE, and (2) patients with CAE more frequently developed nonfatal MI and cardiac death. These findings suggest that CAE may be an important morphological characteristic of coronary artery causing cardiac events.
CAE has generally been defined according to the ratio of the size of ectatic segment to that of the adjacent normal reference segment. 4, 13 However, as shown in Figure 2 , this method is not applicable to patients with diffuse CAE because of the absence of normal reference segments. Krüger et al 14 developed another definition of CAE that used the mean size of each coronary segment in an age-and sex-matched cohort without heart disease as a reference value. In our study, the conventional definition of CAE was inapplicable to 17 patients (33%), who were, therefore, diagnosed using Kruger's definition. Consequently, we identified CAE in 3% of the study population, which was within the range of the previously reported prevalence (0.9%-5.3%). 4, 6, 13, 15, 16 As such, patients with diffuse CAE might be underdiagnosed when the conventional definition alone is used. The use of both definitions is more rigorous but still practical for properly identifying ectatic segments within coronary arteries.
As reported previously, patients with CAE in this study exhibited distinct clinical characteristics, such as more frequent involvement of the right coronary artery, 6,13,16,17 a lower (9) 14 (28) 130 (8) Cardiac death, n (%) 97 (6) 7 (14) 90 (5) Nonfatal MI, n (%) 47 (3) 7 (14) 40 (2) Nonfatal MI at segment with CAE, n (%) … 5 (10) … Categorical variables are expressed as n (%). CAE indicates coronary artery ectasia; MACE, major adverse cardiac events; and MI, myocardial infarction. Unadjusted hazard ratios for MACE were calculated by a univariate Cox proportional hazards model. Adjusted hazard ratios were calculated by a multivariate Cox proportional hazards model using stepwise selection with a P value of 0.05 for backward elimination. This model included the following variables: age, sex, smoking, BMI ≥30 kg/m 2 , STEMI, Killip class ≥2, triple vessel disease, Gensini score, primary PCI, peak levels of CK, LVEF, and CAE. Variable selection in multivariable models was guided by bootstrap selection. A resampling analysis with 200 iteration was performed to identify the variables that entered into 50% of the Cox proportional hazards models to determine the independent predictor of MACE (selection criterion: P<0.10). The 95% CIs of the covariates in the final predictive models were also obtained from the bootstrapped resampling model. BMI indicates body mass index; CAE, coronary artery ectasia; CI, confidence interval; CK, creatine kinase; HR, hazard ratio; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac events; PCI, percutaneous coronary intervention; and STEMI, ST-segment-elevation myocardial infarction.
frequency of stent implantation, and final Thrombolysis in Acute Myocardial Infarction flow grade 3. 16, 17 Moreover, enlargement of other vessels was identified in 37% of patients with CAE. Mechanistically, both atherosclerosis and nonatherosclerotic pathogeneses [18] [19] [20] [21] have been considered to cause CAE, and these potentially affect other systemic arteries as well. Although our CAE subjects were more likely to show clustering of coronary risks, 2 CAE cases had polycystic kidney disease or a connective tissue disorder accompanied by dilated intracranial arteries or descending thoracic aorta. As such, the influence of CAE-related pathogeneses on noncoronary vessels underscores the importance of meticulous screening of systemic arteries in CAE subjects.
The current study analyzing 1698 patients with AMI demonstrated that the presence of CAE was significantly associated with an increased risk of MACE during the 49-month observation period. Moreover, >70% of nonfatal MI in CAE subjects occurred at nonobstructive ectatic coronary segments. Mechanistically, dilatation of vessel size has been shown to slow coronary flow velocity, which increases blood viscosity and promotes coagulation. 12 This pathophysiological element might result in thrombotic occlusion of ectatic coronary arteries. Another possible mechanism is an increased level of inflammatory cytokines, such as tumor necrosis factor-α and interleukin-1β, in CAE subjects. 8 Because these cytokines stimulate the synthesis of tissue factor, which activates the coagulation cascade, a more inflamed substrate in CAE subjects might account for an increased risk of acute coronary events.
Our findings are different from previous studies which did not identified association between CAE and cardiac eve nts. 4, 13, 16, 17, [22] [23] [24] This might be partly because of analyzing patients with stable coronary artery disease in other published studies. Because risk of cardiac events in stable coronary artery disease subjects is lower compared with those with AMI, it may be difficult to detect significant differences in clinical outcomes between stable coronary artery disease subjects with and without CAE. Longer observational period in our study might have enabled to elucidate worse outcomes in patients with CAE.
In this study, subjects who achieved %TTR ≥60% with warfarin therapy exhibited a lower occurrence of MACE compared with those with %TTR <60% or without anticoagulation therapy. Given a significant reduction of thrombotic events in patients with optimal control of %TTR with warfarin, 9 this observation might underscore the importance of carefully monitoring the international normalization ratio in CAE subjects. Further investigation is warranted to evaluate the clinical efficacy of anticoagulation therapy in CAE subjects.
Several caveats should be noted. This was an observational study at a single center that included relatively small numbers of patients with CAE and cardiac events. Despite these limitations, a multivariate Cox proportional hazards model and propensity score-matched analyses consistently showed a significant relationship between CAE and cardiac events. The frequency of statin use was only 55% because guidelines before 2007 did not recommend early statin therapy in patients with AMI. Management based on current therapeutic guidelines might affect the clinical outcomes in our study. Anticoagulation therapy was initiated according to each physician's discretion, a procedure that is susceptible to selection bias.
In conclusion, the presence of CAE predicted the future occurrence of nonfatal MI and cardiac death in the setting of AMI. Our findings highlight CAE as a high-risk vascular phenotype requiring additional pharmacological approaches to optimally control the coagulation cascade. 
